BRIEF published on 05/06/2026 at 01:25, 4 months 5 days ago Empress Royalty Grants Stock Options and Equity Incentives Stock Options TSX Venture Exchange Common Shares Empress Royalty Equity Incentives
BRIEF published on 05/06/2026 at 01:25, 4 months 5 days ago Empress Royalty octroie des options d'achat d'actions et des incitations en actions Options D'achat D'actions Actions Ordinaires Bourse De Croissance TSX Incitations En Actions Impératrice Royale
BRIEF published on 05/06/2026 at 00:25, 4 months 5 days ago Hillcrest Energy Technologies Shifts to Semi-Annual Reporting Financial Framework Canadian Securities Hillcrest Energy Semi-annual Reporting Venture Issuer
BRIEF published on 05/06/2026 at 00:25, 4 months 5 days ago Hillcrest Energy Technologies passe à un rapport semestriel Rapport Semestriel Valeurs Mobilières Canadiennes Cadre Financier Hillcrest Energy Émetteur De Capital-risque
BRIEF published on 05/06/2026 at 00:10, 4 months 5 days ago Study Reveals Rising Stroke Rates and Increasing Inequalities Prevention Efforts Socioeconomic Impact Stroke Rates Ethnic Disparities Healthcare Inequalities
BRIEF published on 05/06/2026 at 00:10, 4 months 5 days ago Une étude révèle une hausse des taux d'AVC et une augmentation des inégalités Impact Socio-économique Taux D'AVC Disparités Ethniques Inégalités En Matière De Soins De Santé Efforts De Prévention
BRIEF published on 05/06/2026 at 00:05, 4 months 5 days ago Onco-Innovations and GSK Collaborate to Enhance Oncology Evidence Clinical Trials Oncology GSK Real-world Data Onco-Innovations
BRIEF published on 05/06/2026 at 00:05, 4 months 5 days ago Onco-Innovations et GSK collaborent pour améliorer les données probantes en oncologie GSK Essais Cliniques Données Du Monde Réel Oncologie Onco-Innovations
BRIEF published on 05/05/2026 at 23:10, 4 months 5 days ago Norgine Secures TGA Approval for PEDMARQSI® in Australia Childhood Cancer TGA Approval PEDMARQSI® Cisplatin Hearing Loss Norgine Pharmaceuticals
BRIEF published on 05/05/2026 at 23:10, 4 months 5 days ago Norgine obtient l'approbation de la TGA pour PEDMARQSI® en Australie PEDMARQSI® Norgine Pharmaceuticals Approbation De La TGA Perte Auditive Due Au Cisplatine Cancer Infantile
Published on 09/11/2026 at 15:00, 24 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 54 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 1 hour 26 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 2 hours 24 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 11 hours 24 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/11/2026 at 14:35, 48 minutes ago EQS-Adhoc: Österreichische Post AG: AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Published on 09/11/2026 at 14:11, 1 hour 12 minutes ago Custodian Property Income REIT plc: Share Buyback
Published on 09/11/2026 at 07:00, 8 hours 24 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 8 hours 24 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 8 hours 24 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 19 hours 54 minutes ago Availability of the 2026 Interim Financial Report
